Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ).
Daito Pharmaceutical Co., Ltd. has announced a strategic move to acquire and subsequently cancel a significant portion of its treasury shares, amounting to up to 1,250,000 shares or 4.2% of the total shares issued. This decision, part of the company’s Medium-Term Management Plan, aims to enhance shareholder returns and improve capital efficiency, reflecting a proactive approach to capital management and shareholder value enhancement.
The most recent analyst rating on (JP:4577) stock is a Hold with a Yen1261.00 price target. To see the full list of analyst forecasts on Daito Pharmaceutical Co., Ltd. stock, see the JP:4577 Stock Forecast page.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 72,427
Technical Sentiment Signal: Buy
Current Market Cap: Yen35.93B
Find detailed analytics on 4577 stock on TipRanks’ Stock Analysis page.